SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-20-004102
Filing Date
2020-02-26
Accepted
2020-02-26 11:15:53
Documents
14
Period of Report
2020-02-26
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8k.htm   iXBRL 8-K 26199
2 EXHIBIT 99.1 ex99_1.htm EX-99.1 476847
6 image00001.jpg GRAPHIC 5065
  Complete submission text file 0001140361-20-004102.txt   676393

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ions-20200226.xsd EX-101.SCH 4198
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ions-20200226_lab.xml EX-101.LAB 22718
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ions-20200226_pre.xml EX-101.PRE 16218
15 EXTRACTED XBRL INSTANCE DOCUMENT form8k_htm.xml XML 4078
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

IRS No.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19125 | Film No.: 20653762
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences